25I-NBOMe

Current official national law expressly controls 25I-NBOMe in United States; unauthorized possession, supply, or manufacture is prohibited.

As at 27 August 2026, the Federal Register marks the June 2026 Poisons Standard as in force. Its Schedule 9 generic entry captures 25I-NBOMe as a substituted alkoxyphenylethylamine. Schedule 9 describes manufacture, possession, supply and use as prohibited by law except approved medical or scientific research and approved analytical, teaching or training purposes. The Schedules are incorporated through State and Territory law, and the Poisons Standard has no direct application in its own right; domestic possession, manufacture, supply and use penalties therefore vary by implementing jurisdiction. At the Commonwealth border, Customs regulation 5 prohibits importing a Schedule 4 drug unless the importer holds the required licence and drug-specific permission, produces the permission, imports within its period and quantity, subject to the regulation's approval and prescribed-medical passenger exceptions. The exact 25I-NBOMe identity is item 5B of Customs Schedule 4 and item 107 of Criminal Code Regulations Schedule 2. Item 107 sets a 0.002 kg (2 g) commercial quantity and 0.002 g (2 mg) marketable quantity. Criminal Code sections 307.1, 307.2 and 307.3 provide maximum federal import/export penalties respectively of life imprisonment or 7,500 penalty units (or both) for a commercial quantity, 25 years or 5,000 penalty units (or both) for a marketable quantity, and 10 years or 2,000 penalty units (or both) for any border-controlled drug. The Crimes (Amount of a Penalty Unit) Instrument 2026 sets one penalty unit at $364 for offences committed on or after 1 July 2026, so those fine maxima are $2,730,000, $1,820,000 and $728,000 respectively. These maxima apply to federal import and export offences; State and Territory domestic offences and penalties vary by jurisdiction.

Austria's current Suchtgiftverordnung lists 25I-NBOMe, also named 2C-I-NBOMe, in Annex V.1; the listing took effect at the end of 26 June 2019. Section 27(1) of the Suchtmittelgesetz makes acquisition, possession, production, transport, import, export, offering, transfer or procurement for another person contrary to law punishable by up to one year's imprisonment or a fine of up to 360 daily rates. For offenses committed exclusively for personal use, § 27(2) sets a maximum of six months' imprisonment or a fine of up to 360 daily rates.

25I-NBOMe appears by name in Lista F2 of the current annex to Portaria SVS/MS nº 344/1998, the list of psychotropic substances whose use is proscribed in Brazil. Under Lei nº 11.343/2006, substances on federal executive lists are drugs, and drugs are prohibited throughout Brazil except where authorized by law or regulation. Unauthorized acquisition, possession, storage, transport, or carrying for personal consumption is subject to the measures in Article 28; the trafficking conduct enumerated in Article 33 is punishable by five to fifteen years' imprisonment and 500 to 1,500 day-fines.

Current official national law expressly controls 25I-NBOMe in Canada; unauthorized possession, supply, or manufacture is prohibited.

Became a controlled substance in October 2015. It remains expressly named in the 2025 national catalog as 2C-I-NBOMe (CAS 919797-19-6). Article 4 prohibits any entity or individual from producing, trading, transporting, using, storing, importing, or exporting listed non-medical narcotic drugs and psychotropic substances; specified research, experimental, reference-standard, and manufacturing-intermediate uses are governed by applicable rules.

25I-NBOMe (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine; 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine) is not separately named in the current Danish order, but its N-(2-methoxybenzyl)-2-phenylethan-1-amine core and 2,5-dimethoxy/4-iodo ring substitutions fall within List B no. 460's generic phenethylamine-group definition. List B substances may be used only for medical or scientific purposes. The order's ordinary rules restrict import, export, sale, purchase, delivery, receipt, manufacture, processing and possession to authorized channels; unauthorized violations are punishable under the Act on Euphoriant Substances § 3 by a fine or imprisonment up to 2 years, with the statutory aggravation for repeated sale of a particularly dangerous or harmful substance and sale or gratuitous transfer for later sale at restaurants, concerts, festivals or similar youth-oriented events. The current order entered into force on 29 March 2026 and repealed BEK nr. 2446 of 12 December 2021. The generic entry excludes specified compounds (including 2C-B, DMA, DOET, DOM, MDMA, mescaline, MMDA, N-ethyl MDA, PMA, PMMA, tenamfetamine and TMA); 25I-NBOMe is not among those exclusions.

Finland's current narcotics decree expressly lists 25I-NBOMe in Annex II under Schedule I of the 1971 Convention on Psychotropic Substances. Under section 3 of the Narcotics Act, substances in Schedules I–IV of that Convention are narcotics. Section 5 prohibits possession and use, subject to exceptions separately provided by law for medical, research, control and industrial purposes.

Current official national law expressly controls 25I-NBOMe in Germany; unauthorized possession, supply, or manufacture is prohibited.

Hungary's current controlled-substances regulation expressly lists 25I-NBOMe, also named 2C-I-NBOMe, in Annex 2, P1, row 4, and identifies it as 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine. Under section 3(1) of Government Decree 66/2012, production, manufacture, export, import, transfer, acquisition, distribution, warehousing, storage, possession, handover and use of psychotropic substances require an activity licence, subject to the decree's stated exceptions. Section 4(7) permits use of P1 substances only for research or industrial purposes, apart from the statutory exception it cites.

Israel expressly lists 25I-NBOMe in the First Schedule to the Dangerous Drugs Ordinance, rather than relying on an analogue inference. The 2013 amendment notice identifies the exact chemical name and synonym and provides that it commences on the date of publication. The Knesset committee approved the amendment on 6 May 2013, but the notice's publication date governs commencement. The Ordinance's definition extends dangerous-drug controls to the listed substance's salts and to preparations, compounds, mixtures and solutions containing it. Section 6 prohibits growing, producing, extracting or preparing a dangerous drug without a Director's licence. Section 7 prohibits possession or use unless permitted by the Ordinance, its regulations or a Director's licence; lawful transit is excepted. Section 13 prohibits export, import, facilitating export/import, trade, any other transaction and supply (whether paid or free) unless authorized, and §14 prohibits brokering those transactions. Section 19A sets a maximum of 20 years' imprisonment (or the statutory fine multiplier) for violations of the commerce/transit part. Under §7(c), ordinary unauthorized possession/use carries up to 20 years (or the statutory fine multiplier), but possession/use solely for personal consumption carries up to 3 years (or the ordinary statutory fine); §7(d) raises the maximum to 5 years for a non-student who possesses/uses solely for personal consumption inside a school or its grounds, and excludes persons under 16. These personal-use and transit exceptions are limitations on penalty/scope, not legalization of 25I-NBOMe.

The current Ministry of Health Tabella I lists 25I-NBOMe and its chemical name. Classified as a Schedule 1 controlled substance.³⁹ The Decree of 10 February 2015 inserted the substance into Tabella I and took effect on the fifteenth day after its publication on 27 February 2015. Under Article 73 of D.P.R. 309/1990, unauthorized production, sale and distribution of a Tabella I substance are criminal offences, as is unauthorized possession where the circumstances show that the substance is intended for non-personal use. Under Article 75, unlawful possession for personal use is instead subject to administrative sanctions.

25I-NBOMe and its salts have been designated as narcotics since 1 November 2015 and remain listed in the current designation decree. The Narcotics and Psychotropics Control Act restricts manufacture, import, export, transfer, receipt, possession, and administration to licensed or otherwise authorized circumstances, with unauthorized conduct subject to criminal penalties.

25I-NBOMe is 2,5-dimethoxy-4-iodo-N-(2-methoxybenzyl)phenethylamine. It is not named individually in Latvia's current Annex 2, but falls within the List I generic class for 2,5-dimethoxyphenethylamines in Part II, item 11(1): iodine replaces a hydrogen on the benzene ring, and the 2-methoxybenzyl group is a substituted alkyl group replacing a hydrogen on nitrogen. Section 5 of the lawful-circulation law prohibits cultivation, production, manufacture, import, export, distribution, advertising, transport, storage, transfer for or without payment, acquisition, use and transit through Latvia of List I substances. Section 7 permits authorized handling for specified scientific research, determination of physical and chemical properties, and training.

Classified as a Lijst 1 substance under the Opiumwet (Opium Law).⁴⁹ The current consolidated Opiumwet continues to list 25I-NBOMe in Lijst I. Article 2 in principle prohibits bringing a Lijst I substance into or outside the Netherlands, cultivating, preparing, processing, selling, delivering, supplying, transporting, possessing, and manufacturing it. Article 5 makes limited exceptions. Its professional and veterinary exceptions apply only to substances designated under article 4 and the stated professional conditions. Other provisions cover designated institutions and lawfully acquired quantities needed for medical or statutory purposes, persons or institutions designated during a declared emergency, and transport or possession on the instructions of someone authorized to transport. Articles 6 and 8 allow ministerial exemptions for qualifying health, research, instructional, contractual, or industrial purposes.

Classified as a Schedule 2 controlled substance under New Zealand drug legislation.⁵²

The 29 February 2024 amendment replaced the Narkotikalisten table and expressly listed 2C-I-NBOMe (25I-NBOMe), CAS 919797-19-6, in international category P I as prohibited under § 5. The current consolidated Narkotikalisten retains the same classification.

25I-NBOMe is expressly listed as item 16 among Poland's Group I-P psychotropic substances. Group I-P substances may be used only for research. Unauthorized manufacture, placing on the market or participation in such trade, and possession are criminal offences under Articles 53, 56 and 62 of the Act on Counteracting Drug Addiction.

Romania expressly lists 25I-NBOMe by name and chemical identity in Table I of Law No. 143/2000. Table I substances are classed as high-risk drugs. Articles 2(2) and 4(2) make unauthorized circulation operations and unauthorized purchase or possession for personal consumption, respectively, punishable.

The official current schedule does not list a standalone entry named 25I-NBOMe, 2C-I-NBOMe or 2-(4-йод-2,5-диметоксифенил)-N-(2-метоксибензил)этанамин. It does show the specific parent NBOMe entry 2-(2,5-диметоксифенил)-N-(2-метоксибензил)этанамин и его производные (introduced by Government Resolution No. 448 of 8 May 2015). The schedule also separately contains the broader 2,5-Диметоксифенэтиламин derivative entry, but its application is subject to Resolution 681 Note 6's structural conditions, including a carbon-count limit that can matter for N-benzyl derivatives. Resolution 681 Note 6 defines a derivative as a substance outside the state medicines register and list whose structure is formed by formal substitution of hydrogen, halogen and/or hydroxyl atoms by other permitted substituents, subject to the note's carbon-count and other conditions. 25I-NBOMe's para-iodo substitution from the listed NBOMe parent is therefore the schedule-based reason it is covered, provided the sample is in fact that compound and no statutory exclusion or separate listing applies. List I is the prohibited-turnover list under Resolution 681 and Federal Law No. 3-FZ Article 2; this is not a prescription-only classification. Resolution No. 1002 lists the NBOMe parent-and-derivatives row at more than 0.05 g (significant), more than 0.25 g (large), and more than 500 g (particularly large), for Criminal Code Articles 228, 228.1, 229 and 229.1. These are criminal-law quantity thresholds, not lawful possession allowances. For unlawful possession, storage, transport, manufacture or processing without intent to sell, Article 228 provides alternatives up to 3 years for significant quantity, 3–10 years for large quantity, and 10–15 years for particularly large quantity; sale, production or forwarding is governed by Article 228.1, whose graduated sanctions run from 4–8 years (part 1) through 5–12 years (part 2), 8–15 years (part 3), 10–20 years (part 4), and 15–20 years or life imprisonment (part 5), depending on conduct, quantity and aggravating facts. The EEC official 2025 consolidated reproduction records Resolution No. 822 of 6 October 2011 in the schedule's amendment history; it also records the specific NBOMe parent-class insertion by Resolution No. 448 on 8 May 2015. Exact historic effective dates, sample identity, salt/stereoisomer treatment and any state-register exclusion remain case-specific legal and chemical questions.

The current Serbian schedule expressly lists 25I-NBOMe in List 4, item 70, by name, CAS number and systematic/IUPAC identity. The 2026 rule was published 6 February 2026, takes effect on the eighth day after publication, and repealed the prior 77/2024 list. Serbian law generally prohibits production, wholesale traffic (including import, export, transit, transport, storage, distribution, sale, purchase and brokering), use and delivery of psychoactive controlled substances except under statutory authorization; List 4 substances are limited to scientific research and only exceptionally therapeutic use. Authorized production/traffic requires a Ministry permit for the specific substance, quantity and premises, while research possession requires ministerial consent. Article 108 sets an economic-offense fine of RSD 1,000,000–3,000,000 for a legal person unlawfully producing or trafficking psychoactive controlled substances, plus RSD 100,000–200,000 for the responsible person; Article 110 permits a 3–10 year business prohibition and confiscation. Criminal Code provisions apply to production, traffic, use and delivery under the psychoactive-substances law; Articles 246 and 246a provide the cited narcotic-drug trafficking and possession ranges, subject to the Code's opojne-droge characterization and facts.

The exact compound is listed in Group I.

Added to the Medical Products Agency's narcotics lists under Swedish Schedule I (substances that normally do not have medical use) effective August 1, 2013. Published by the Medical Products Agency in regulation LVFS 2013:15.⁸¹ The current consolidated LVFS 2011:10 continues to list 25I-NBOMe, also named 2C-I-NBOMe, in Swedish list I. Annex 1 to the current Förordning (1992:1554) om kontroll av narkotika separately names 25I-NBOMe as a substance deemed narcotic under Narkotikastrafflag (1968:64). Section 1 of Narkotikastrafflag punishes unauthorized transfer, manufacture intended for abuse, acquisition for transfer, specified handling not intended for personal use, and possession, use, or other handling.

Specifically named as a controlled substance under Verzeichnis D of Swiss narcotics legislation.⁸⁵

Taiwan's official FDA schedule currently places 25I-NBOMe in Class 2, not Class 4. The exact listed identity is 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(methoxybenzyl)ethanamine (Chinese: 2-(4-碘-2,5-二甲氧基苯基)-N-(甲氧基苄基)乙胺), and the entry expressly includes the isomers 25I-NB4OMe (2C-I-NB4OMe), 25I-NBOMe (2C-I-NBOMe), and 25I-NB3OMe (2C-I-NB3OMe). The current list's general scope also includes isomers, esters, ethers and salts unless a special exception is stated; a limited non-human laboratory-test-preparation exception applies where the listed concentration and package thresholds and anti-abuse conditions are all met. The entry was added as a Class 2 controlled drug by Executive Yuan announcement院臺衛字第1110005238號, effective 8 March 2022. Appendix II of the consolidated Narcotics Hazard Prevention Act separately confirms the same identity/isomer entry as a second-level narcotic, so second-level narcotics offenses apply: manufacture, transport or sale (Art. 4(2): life imprisonment or 10+ years, plus up to NT$15 million); possession with intent to sell (Art. 5(2): 5+ years, plus up to NT$5 million); transfer (Art. 8(2): 6 months to 5 years, plus up to NT$700,000); use (Art. 10(2): up to 3 years); ordinary possession (Art. 11(2): up to 2 years, detention or up to NT$200,000), with pure net weight of at least 20 grams increasing possession penalty to 6 months–5 years plus up to NT$700,000 (Art. 11(4)). These are statutory provisions subject to the Act's other exceptions, aggravators and judicial determination; 25I-NBF and 25I-NBOH are different entries and should not be conflated with 25I-NBOMe.

The current UAE legislation portal identifies Federal Law by Decree No. (30) of 2021 as Active, effective 02 January 2022, with the last update listed as 01 October 2025 and three amendments. Schedule 5 item 17 expressly lists 25I-NBOMe/2C-I-NBOMe by the chemical identity 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine under Phenethylamines. The schedule also covers included stereoisomers where possible, plus derivatives, metabolites, salts and preparations wherever their presence is possible and in any proportion, unless specifically excluded. Article 10(1) prohibits importing, exporting, transferring, producing, manufacturing, bringing into the UAE, possessing, acquiring and related acts for Schedule 5 substances; medical monitoring and scientific research are possible only under the Article 10(2) authority and procedure. Article 57 routes Article 10(1) violations to Schedule 10: for Schedule 5 substances, Group 1 provides imprisonment plus a fine of at least AED 100,000 for less than 20 g (with personal-use cases handled under Articles 41-42), at least 10 years and at least AED 100,000 for 20-100 g, and life imprisonment plus at least AED 500,000 above 100 g. Article 57 further provides the death penalty where the Article 10 crime is committed with intent to traffic or promote. Article 41 separately sets first personal-use/addiction penalties for Schedule 5 substances at imprisonment of at least three months or AED 20,000-100,000, with higher repeat-offense penalties. These are statutory ranges and exceptions; the law does not make recreational use lawful.

Current official national law expressly controls 25I-NBOMe in United Kingdom; unauthorized possession, supply, or manufacture is prohibited.